TY - JOUR T1 - Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase T2 - potential for drug development A1 - Eoh,Hyungjin A1 - Brown,Amanda C. A1 - Buetow,Lori A1 - Hunter,William N. A1 - Parish,Tanya A1 - Kaur,Devinder A1 - Brennan,Patrick J. A1 - Crick,Dean C. AU - Eoh,Hyungjin AU - Brown,Amanda C. AU - Buetow,Lori AU - Hunter,William N. AU - Parish,Tanya AU - Kaur,Devinder AU - Brennan,Patrick J. AU - Crick,Dean C. PY - 2007/12 Y1 - 2007/12 N2 -

Mycobacterium tuberculosis utilizes the methylerythritol phosphate (MEP) pathway for biosynthesis of isopentenyl diphosphate and its isomer, dimethylallyl diphosphate, precursors of all isoprenoid compounds. This pathway is of interest as a source of new drug targets, as it is absent from humans and disruption of the responsible genes has shown a lethal phenotype for Escherichia coli. In the MEP pathway, 4-diphosphocytidyl-2-C-methyl-D-erythritol is formed from 2-C-methyl-D-erythritol 4-phosphate (MEP) and CTP in a reaction catalyzed by a 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (IspD). In the present work, we demonstrate that Rv3582c is essential for M. tuberculosis: Rv3582c has been cloned and expressed, and the encoded protein has been purified. The purified M. tuberculosis IspD protein was capable of catalyzing the formation of 4-diphosphocytidyl-2-C-methyl-D-erythritol in the presence of MEP and CTP. The enzyme was active over a broad pH range (pH 6.0 to 9.0), with peak activity at pH 8.0. The activity was absolutely dependent upon divalent cations, with 20 mM Mg2+ being optimal, and replacement of CTP with other nucleotide 5'-triphosphates did not support activity. Under the conditions tested, M. tuberculosis IspD had K-m values of 58.5 mu M for MEP and 53.2 mu M for CTP. Calculated k(cat) and k(cat)/K-m values were 0.72 min(-1) and 12.3 mM(-1) min(-1) for MEP and 1.0 min(-1) and 18.8 mM(-1) min(-1) for CTP, respectively.

AB -

Mycobacterium tuberculosis utilizes the methylerythritol phosphate (MEP) pathway for biosynthesis of isopentenyl diphosphate and its isomer, dimethylallyl diphosphate, precursors of all isoprenoid compounds. This pathway is of interest as a source of new drug targets, as it is absent from humans and disruption of the responsible genes has shown a lethal phenotype for Escherichia coli. In the MEP pathway, 4-diphosphocytidyl-2-C-methyl-D-erythritol is formed from 2-C-methyl-D-erythritol 4-phosphate (MEP) and CTP in a reaction catalyzed by a 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase (IspD). In the present work, we demonstrate that Rv3582c is essential for M. tuberculosis: Rv3582c has been cloned and expressed, and the encoded protein has been purified. The purified M. tuberculosis IspD protein was capable of catalyzing the formation of 4-diphosphocytidyl-2-C-methyl-D-erythritol in the presence of MEP and CTP. The enzyme was active over a broad pH range (pH 6.0 to 9.0), with peak activity at pH 8.0. The activity was absolutely dependent upon divalent cations, with 20 mM Mg2+ being optimal, and replacement of CTP with other nucleotide 5'-triphosphates did not support activity. Under the conditions tested, M. tuberculosis IspD had K-m values of 58.5 mu M for MEP and 53.2 mu M for CTP. Calculated k(cat) and k(cat)/K-m values were 0.72 min(-1) and 12.3 mM(-1) min(-1) for MEP and 1.0 min(-1) and 18.8 mM(-1) min(-1) for CTP, respectively.

KW - ESCHERICHIA-COLI KW - ISOPRENOID BIOSYNTHESIS KW - LETHAL MUTATIONS KW - CELL-WALL KW - GENE KW - 1-DEOXY-D-XYLULOSE KW - IDENTIFICATION KW - 5-PHOSPHATE KW - INTERMEDIATE KW - MUTAGENESIS U2 - 10.1128/JB.00925-07 DO - 10.1128/JB.00925-07 M1 - Article JO - Journal of Bacteriology JF - Journal of Bacteriology SN - 0021-9193 IS - 24 VL - 189 SP - 8922 EP - 8927 ER -